GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » Other Long Term Assets

Merck (BSP:MRCK34) Other Long Term Assets : R$58,778 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Merck Other Long Term Assets?

Merck's other long-term assets for the quarter that ended in Dec. 2023 was R$58,778 Mil.

Merck's quarterly other long-term assets increased from Jun. 2023 (R$49,445 Mil) to Sep. 2023 (R$52,148 Mil) and increased from Sep. 2023 (R$52,148 Mil) to Dec. 2023 (R$58,778 Mil).

Merck's annual other long-term assets declined from Dec. 2021 (R$65,495 Mil) to Dec. 2022 (R$49,978 Mil) but then increased from Dec. 2022 (R$49,978 Mil) to Dec. 2023 (R$58,778 Mil).


Merck Other Long Term Assets Historical Data

The historical data trend for Merck's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Other Long Term Assets Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27,791.57 67,169.20 65,495.05 49,978.17 58,778.00

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53,544.41 49,444.64 52,147.73 58,778.00 -

Merck Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Merck (BSP:MRCK34) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BSP:MRCK34) Headlines

No Headlines